Metropolitan Life Insurance Company (MetLife)’s Avient AVNT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AVNT Stock Details AVNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,751	Closed	-$206K	–	219
2024 Q1	$206K	Sell	4,751 -380	-7%	-$14.8K	0.01%	701
2023 Q4	$213K	Sell	5,131 -210	-4%	-$7.33K	0.01%	704
2023 Q3	$189K	Buy	5,341 +347	+7%	+$13.4K	0.01%	707
2023 Q2	$204K	Buy	4,994 +99	+2%	+$3.88K	0.01%	668
2023 Q1	$201K	Sell	4,895 -703	-13%	-$28K	0.01%	663
2022 Q4	$189K	Buy	5,598 +192	+4%	+$6.31K	0.01%	740
2022 Q3	$164K	Hold	5,406	–	–	0.01%	753
2022 Q2	$217K	Sell	5,406 -273	-5%	-$12.9K	0.01%	664
2022 Q1	$273K	Sell	5,679 -32,115	-85%	-$1.66M	0.01%	683
2021 Q4	$2.11M	Sell	37,794 -1,626	-4%	-$89K	0.03%	492
2021 Q3	$1.83M	Sell	39,420 -127	-0.3%	-$6.1K	0.03%	552
2021 Q2	$1.94M	Sell	39,547 -280	-0.7%	-$14.2K	0.03%	537
2021 Q1	$1.88M	Sell	39,827 -400	-1%	-$17.8K	0.03%	549
2020 Q4	$1.62M	Sell	40,227 -1,935	-5%	-$68.2K	0.02%	583
2020 Q3	$1.12M	Sell	42,162 -1,348	-3%	-$35.2K	0.02%	679
2020 Q2	$1.14M	Sell	43,510 -5,987	-12%	-$139K	0.02%	659
2020 Q1	$939K	Buy	49,497 +6,495	+15%	+$182K	0.02%	707
2019 Q4	$1.58M	Sell	43,002 -460	-1%	-$15K	0.03%	665
2019 Q3	$1.42M	Sell	43,462 -2,380	-5%	-$75.5K	0.02%	676
2019 Q2	$1.44M	Buy	45,842 +30	+0.1%	+$840	0.02%	681
2019 Q1	$1.34M	Sell	45,812 -1,075	-2%	-$33.7K	0.02%	706
2018 Q4	$1.34M	Buy	46,887 +532	+1%	+$17.8K	0.03%	640
2018 Q3	$2.03M	Sell	46,355 -49	-0.1%	-$2.14K	0.03%	521
2018 Q2	$2.01M	Buy	46,404 +265	+0.6%	+$11.4K	0.03%	518
2018 Q1	$1.96M	Buy	46,139 +507	+1%	+$21.9K	0.03%	542
2017 Q4	$1.99M	Buy	+45,632	New	+$2.01M	0.03%	552
2017 Q3	–	Sell	-131,733	Closed	-$5.1M	–	2464
2017 Q2	$5.1M	Buy	131,733 +702	+0.5%	+$26.1K	0.04%	560
2017 Q1	$4.47M	Sell	131,031 -2,103	-2%	-$70.5K	0.03%	661
2016 Q4	$4.27M	Sell	133,134 -1,358	-1%	-$43.6K	0.03%	668
2016 Q3	$4.55M	Sell	134,492 -3,561	-3%	-$123K	0.03%	588
2016 Q2	$4.87M	Buy	138,053 +489	+0.4%	+$17.2K	0.04%	532
2016 Q1	$4.16M	Buy	137,564 +1,106	+0.8%	+$30.4K	0.03%	602
2015 Q4	$4.33M	Sell	136,458 -275	-0.2%	-$9.19K	0.03%	566
2015 Q3	$4.01M	Sell	136,733 -695	-0.5%	-$23.5K	0.03%	599
2015 Q2	$5.38M	Sell	137,428 -6,254	-4%	-$244K	0.04%	503
2015 Q1	$5.37M	Sell	143,682 -3,495	-2%	-$133K	0.04%	497
2014 Q4	$5.58M	Buy	147,177 +816	+0.6%	+$29.8K	0.04%	484
2014 Q3	$5.21M	Sell	146,361 -1,174	-0.8%	-$46.1K	0.04%	482
2014 Q2	$6.22M	Buy	147,535 +68,172	+86%	+$2.67M	0.04%	433
2014 Q1	$2.91M	Sell	79,363 -269	-0.3%	-$9.66K	0.02%	799
2013 Q4	$2.81M	Buy	79,632 +2,428	+3%	+$77.3K	0.02%	795
2013 Q3	$2.37M	Sell	77,204 -3,196	-4%	-$90.4K	0.02%	843
2013 Q2	$1.99M	Buy	+80,400	New	+$1.96M	0.02%	889

Other funds holding AVNT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AVNT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Avient (AVNT) in Q2 2024, closing a stake of 4,751 shares — an estimated $206K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AVNT in Q2 2013 and held it in 43 quarters. The position peaked at $6.22M in Q2 2014. 304 funds tracked by Wall St. Rank hold AVNT as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Avient position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 4,751 Avient shares in Q2 2024, an estimated $206K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Avient in Q2 2013 and held it in 43 quarters.
Metropolitan Life Insurance Company (MetLife)'s Avient position peaked at $6.22M in Q2 2014.
304 funds tracked by Wall St. Rank held Avient as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.